ADVANCED GASTROINTESTINAL TUMORS
Clinical trials for ADVANCED GASTROINTESTINAL TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GASTROINTESTINAL TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED GASTROINTESTINAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer combo trial halted early: what we learned
Disease control TerminatedThis study tested a combination of two drugs, donafenib and KN046, in people with advanced gastrointestinal cancers that had not responded to standard treatments. The goal was to check safety and see if the drugs could shrink tumors. The trial was stopped early after enrolling on…
Matched conditions: ADVANCED GASTROINTESTINAL TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Experimental CAR-T therapy targets Hard-to-Treat gut cancers
Disease control TerminatedThis early-phase study tested a new treatment called LCAR-G08, which uses a patient's own immune cells (CAR-T cells) to attack a protein found on certain advanced gastrointestinal tumors. The study involved 17 adults with cancers like colorectal, gastric, or pancreatic cancer tha…
Matched conditions: ADVANCED GASTROINTESTINAL TUMORS
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated May 14, 2026 12:02 UTC